Chargement en cours...
A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with 5-year survival as low as 6%. It is therefore imperative to explore potential treatment avenues to improve survival in these groups of patients. Anti-estrogenic hormone therapy (AEHT) is well-tolerated an...
Enregistré dans:
| Publié dans: | Transl Gastroenterol Hepatol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724184/ https://ncbi.nlm.nih.gov/pubmed/33409403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2020.02.16 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|